Abstract 18395: Safety of Continuing Ivabradine Treatment During Hospitalization for Worsening of Heart Failure in the SHIFT Study

• Published in: Circulation (New York, N.Y.) Vol. 132; no. Suppl_3 Suppl 3; p. A18395
• Main Authors: Borer, Jeffrey, Swedberg, Karl, Komajda, Michel, Ford, Ian, Tavazzi, Luigi, Böhm, Michael, Dominjon, Fabienne, Wu, Yuna, Depre, Christophe, Maya, Juan
• Format: Journal Article
• Language: English
• Published: by the American College of Cardiology Foundation and the American Heart Association, Inc 10.11.2015

BackgroundChronic medical treatment is usually adapted during hospitalizations for worsening heart failure (HWHF). Ivabradine, a heart rate (HR)-slowing agent that inhibits the funny current (If) in the sinus node, when added to standard of care reduced the relative risk of HWHF by 26% in the Systol...